Recent developments indicate that the FDA may expand the use of testosterone therapy to address issues related to libido enhancement. This consideration comes as new research emerges.
The implications of such an expansion could significantly impact treatment options for individuals experiencing low libido, although specific details remain uncertain.
This potential shift in policy is part of a larger conversation within the biotech community, which includes various advancements and ongoing studies in related fields.
Updates
Update at 13:40 UTC on 2026-04-17
STAT reported New research questions GLP-1's purpose, a pancreatic cancer breakthrough, and more biotech news from The Readout.
Sources: STAT